비두부형 모균증의 임상적 고찰 = Clinical Study of Rhinocerebral Mucormycosis

다국어 초록 (Multilingual Abstract)

Background and Objectives：Rhinocerebral mucormycosis is recognized as a potentially aggressive and commonly fatal fungal infection. The classic presentation involves nasal mucosa and the invasion of the paranasal sinuses and orbit. Treatment includes aggressive debridement, systemic antifungal therapy, and control of underlying comorbid factors. This study aimed to investigate the clinical feature of rhinocerebral mucormycosis and to determine relationships among the underlying disease, extent of mucormycosis, initial time of surgical intervention and prognosis. Subjects and Method：Five cases of mucormycosis were retrospectively reviewed. Prognosis was analyzed according to predisposing factors including the underlying disease, extent of disease and intial time of surgical intervention. Resuits：A 5-year overall survival rate of the patients with mucormycosis was 60%. There was significant survival gain in the group for which the underlying disease was well controlled and extent of disease was limited, No significant difference in survival was observed according to duration between symptom onset and surgical intervention. Conclusion：Survival is usually determined at the very early period of treatment. The most important prognostic factor is optimal control of the underlying disease and extent of disease.

참고문헌 (Reference)

1 Jeon EJ, "Two Cases of rhino-orbito-cerebralmucormycosis" 44 : 666-70, 2001

2 Weber RS, "Treatment of invasive Aspergillus sinusitiswith liposonal-amphotericin B" 97 : 937-41, 1987

3 Christenson JC, "Synergisticaction of amphotericin B and rifampin against rhizopus species" 31 : 1775-8, 1987

4 Fisher EW, "Rhinocerebral mucormycosis:Use of liposomal amphoterican B" 105 : 575-7, 1991

5 Peterson KL, "Rhinocerebral mucormycosis:Evolution of the disease and treatment options" 107 : 855-62, 1997

6 Jin YW, "Rhinocerebral mucormycosis withselective cranial nerve palsy" 44 : 674-7, 2001

7 Talmi YP, "Rhino-orbital and rhino-orbito-cerebral mucormycosis" 127 : 22-31, 2002

8 Lee MC, "Prognostic factor of invasive fungal sinusitis" 46 : 841-5, 2003

9 Harris JS, "Mucormycosis report of a case" 16 : 857-67, 1955

10 Finn DG, "Mucormycosis of the paranasal sinuses" 816 821-8 2,

11 Ferguson BJ, "Mucormycosis of the nose and paranasal sinuses" 33 : 349-65, 2000

12 Brown OE, "Mucormycosis of the mandible" 44 : 132-6, 1986

13 Sugar AM, "Mucormycosis" 14 : -9, 1992

14 Jiang RS, "Endoscopic sinus surgery for rhinocerebral mucormycosis" 13 : 105-9, 1999

15 Vessely MB, "Atypical presentationsof mucormycosis in the head and neck" 115 : 573-7, 1996

16 Gillespie MB, "An algorithmic approach to the diagnosisand management of invasive fungal rhinosinusitis in the immunocompromisedpatient" 33 : 323-34, 2000

17 Ferguson BJ, "Adjunctivehyperbaric oxygen for treatment of rhinocerebral mucormycosis" 10 : 551-9, 1988

18 Kim YB, "3 Case of rhinoparanasal mucormycosis" 38 : 1810-15, 1995